| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $317.0M | — | +19.2% |
| Cost of Revenue | $40.0M | — | -9.1% |
| Gross Profit | $277.0M | — | +25.3% |
| R&D Expense | $16.0M | — | -27.3% |
| SG&A Expense | $124.0M | — | -6.1% |
| Operating Income | $137.0M | — | +107.6% |
| Pre-tax Income | $115.0M | — | +94.9% |
| Income Tax | $26.0M | — | +136.4% |
| Net Income | $89.0M | — | +89.4% |
| EPS (Basic) | $0.71 | — | +86.8% |
| EPS (Diluted) | $0.69 | — | +81.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $175.0M | -10.3% | -53.0% |
| Accounts Receivable | $273.0M | +7.9% | +12.3% |
| Inventory | $152.0M | -0.7% | -6.7% |
| Current Assets | $667.0M | +2.3% | -24.5% |
| Total Assets | $1.20B | -0.3% | -12.9% |
| Current Liabilities | $779.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.0M | — | -112.0% |
| Capital Expenditures | $20.0M | — | +300.0% |
| Investing Cash Flow | -$19.0M | — | -280.0% |
| Financing Cash Flow | $7.0M | — | +141.2% |
| Free Cash Flow | -$29.0M | — | -141.4% |
| -22.5% |
| Long-term Debt | $486.0M | +67.6% | +56.3% |
| Total Liabilities | $1.34B | +3.2% | -19.2% |
| Stockholders' Equity | -$144.0M | -46.9% | +49.5% |